Lung Cancers Withdrawn Phase 1 / 2 Trials for Bortezomib (DB00188)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

DBCOND0072929 (Lung Cancers)Withdrawn1 / 2 IdentifierTitlePurposeDrugs
NCT00411593Phase I-II for Patients With Recurrent or Refractory Non-small Cell Lung Cancer (NSCLC)Treatment
NCT00313690Cancer Treatment Followed by Surgery for Early Stage Non-small Cell Lung CancerTreatment